Sterically Hindered Derivatives of Pentacene and Octafluoropentacene.

6,13-Diethynylpentacene derivatives with sterically bulky substituents (Tr*, tris(3,5-di-tert-butylphenyl)methyl groups) appended to the ethynyl moieties at the 6- and 13-positions have been synthesized, as well as derivatives with electron-withdrawing fluorine groups on the 1,2,3,4,8,9,10,11-positions. These molecules are designed to investigate relationships between steric and electronic effects on the stability of pentacene toward endoperoxide formation via reaction with photosensitized oxygen in solution under ambient light (i. e.

What to expect from rational drug design.

For more than 20 years, rational methods of drug design have belonged to the methodological core of drug development. Rational drug design based on structural knowledge of protein targets and on computational modelling of drug-target interaction holds out the promise of a predictable development process for highly innovative drugs. Still, it remains a challenge to make the available structural information fruitful for lead design.

Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.

Rational drug design is a method for developing new pharmaceuticals that typically involves the elucidation of fundamental physiological mechanisms. It thus combines the quest for a scientific understanding of natural phenomena with the design of useful technology and hence integrates epistemic and practical aims of research and development. Case studies of the rational design of the cardiovascular drugs propranolol, captopril and losartan provide insights into characteristics and conditions of this integration.